{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:55:38Z","timestamp":1790931338039,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Medical Health Science and Technology Project of the Zhejiang Provincial Health Commission","award":["2025HY0232"],"award-info":[{"award-number":["2025HY0232"]}],"id":[{"id":"https:\/\/ror.org\/00va36f15","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00259-026-08088-7","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:36:32Z","timestamp":1784709392000},"page":"7204-7220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative PET\/CT phenotype of gastric-type endocervical adenocarcinoma: integrated morphological, metabolic, serological, and explainable machine-learning analysis"],"prefix":"10.1007","volume":"53","author":[{"given":"Yun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heqing","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8077-8407","authenticated-orcid":false,"given":"Ye","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"10","key":"8088_CR1","doi-asserted-by":"publisher","first-page":"e1189","DOI":"10.1016\/j.crad.2024.04.016","volume":"79","author":"N Kikkawa","year":"2024","unstructured":"Kikkawa N, Sugawara H, Yoshida H, Kobayashi-Kato M, Tanase Y, Uno M, Ishikawa M, Kato T, Kusumoto M. Characteristics of the magnetic resonance imaging findings of cervical gastric-type adenocarcinoma. Clin Radiol. 2024;79(10):e1189\u201395. https:\/\/doi.org\/10.1016\/j.crad.2024.04.016.","journal-title":"Clin Radiol"},{"issue":"5","key":"8088_CR2","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1245\/s10434-022-13033-7","volume":"30","author":"A Yoshino","year":"2023","unstructured":"Yoshino A, Kobayashi E, Tsuboyama T, Fukui H, Tomiyama N, Sato K, Morii E, Nakatani E, Komura N, Sawada I, et al. Novel strategy for the management of cervical multicystic diseases. Ann Surg Oncol. 2023;30(5):2964\u201373. https:\/\/doi.org\/10.1245\/s10434-022-13033-7.","journal-title":"Ann Surg Oncol"},{"issue":"41","key":"8088_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039957","volume":"103","author":"N Shao","year":"2024","unstructured":"Shao N. Research progress on human papillomavirus-negative cervical cancer: a review. Medicine (Baltimore). 2024;103(41):e39957. https:\/\/doi.org\/10.1097\/MD.0000000000039957.","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"8088_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/curroncol32100530","volume":"32","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhou X, Xi Y, Lou H, Li L, Yi H, Zhu T. PET\/CT imaging characteristics of gastric-type endocervical adenocarcinoma: findings from a small exploratory series. Curr Oncol. 2025;32(10):530. https:\/\/doi.org\/10.3390\/curroncol32100530.","journal-title":"Curr Oncol"},{"issue":"10","key":"8088_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/curroncol32100530","volume":"32","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhou X, Xi Y, Lou H, Li L, Yi H, Zhu T. PET\/CT imaging characteristics of gastric-type endocervical adenocarcinoma: Findings from a small exploratory series. Curr Oncol. 2025;32(10):530. https:\/\/doi.org\/10.3390\/curroncol32100530.","journal-title":"Curr Oncol"},{"issue":"10","key":"8088_CR6","doi-asserted-by":"publisher","first-page":"e1189","DOI":"10.1016\/j.crad.2024.04.016","volume":"79","author":"N Kikkawa","year":"2024","unstructured":"Kikkawa N, Sugawara H, Yoshida H, Kobayashi-Kato M, Tanase Y, Uno M, Ishikawa M, Kato T, Kusumoto M. Characteristics of the magnetic resonance imaging findings of cervical gastric-type adenocarcinoma. Clin Radiol. 2024;79(10):e1189\u201395. https:\/\/doi.org\/10.1016\/j.crad.2024.04.016.","journal-title":"Clin Radiol"},{"key":"8088_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s11604-024-01713-1","volume":"43","author":"Y Himoto","year":"2025","unstructured":"Himoto Y, Kido A, Yamanoi K, Kurata Y, Morita S, Kikkawa N, et al. Limited diagnostic performance of imaging evaluation for staging in gastric-type endocervical adenocarcinoma: a multi-center study. Jpn J Radiol. 2025;43:810\u20139. https:\/\/doi.org\/10.1007\/s11604-024-01713-1.","journal-title":"Jpn J Radiol"},{"key":"8088_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2022.110612","volume":"158","author":"T Mori","year":"2023","unstructured":"Mori T, Kato H, Kawaguchi M, Kanayama T, Furui T, Noda Y, et al. MRI characteristics for predicting histological subtypes in patients with uterine cervical adenocarcinoma. Eur J Radiol. 2023;158:110612. https:\/\/doi.org\/10.1016\/j.ejrad.2022.110612.","journal-title":"Eur J Radiol"},{"issue":"2","key":"8088_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1713137","volume":"378","author":"JC Soria","year":"2018","unstructured":"Soria JC, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee KH, et al. Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. N Engl J Med. 2018;378(2):113\u201325.","journal-title":"N Engl J Med"},{"issue":"1","key":"8088_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1913662","volume":"382","author":"SS Ramalingam","year":"2020","unstructured":"Ramalingam SS, Vansteenkiste J, Planchard D, Cho BC, Gray JE, Ohe Y, et al. Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC. N Engl J Med. 2020;382(1):41\u201350.","journal-title":"N Engl J Med"},{"issue":"1","key":"8088_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-15243-0","volume":"25","author":"Y Wang","year":"2025","unstructured":"Wang Y, Su Y, Li J, et al. Machine learning-based differentiation of benign and malignant adrenal lesions using 18F-FDG PET\/CT: a two-stage classification and SHAP interpretation study. BMC Cancer. 2025;25(1):1726.","journal-title":"BMC Cancer"},{"key":"8088_CR12","doi-asserted-by":"publisher","first-page":"1685088","DOI":"10.3389\/fmedt.2025.1685088","volume":"7","author":"Y Su","year":"2025","unstructured":"Su Y, Cai Y, Jin S, et al. Explainable multi-modal machine learning for predicting occult pulmonary metastases in differentiated thyroid cancer: a SHAP-based approach prior to radioactive iodine scans. Front Med Technol. 2025;7:1685088.","journal-title":"Front Med Technol"},{"issue":"6","key":"8088_CR13","doi-asserted-by":"publisher","first-page":"828","DOI":"10.5858\/arpa.2012-0720-OA","volume":"137","author":"NI Lindeman","year":"2013","unstructured":"Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic S, Giaccone G, et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Arch Pathol Lab Med. 2013;137(6):828\u201360.","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"8088_CR14","first-page":"2892","volume":"5","author":"A Midha","year":"2015","unstructured":"Midha A, Dearden S, McCormack R. EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity. Am J Cancer Res. 2015;5(9):2892\u2013911.","journal-title":"Am J Cancer Res"},{"issue":"2","key":"8088_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/JTO.0000000000000033","volume":"9","author":"Y Shi","year":"2014","unstructured":"Shi Y, Au JSK, Thongprasert S, Srinivasan S, Tsai CM, Khoa MT, et al. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER). J Thorac Oncol. 2014;9(2):154\u201362.","journal-title":"J Thorac Oncol"},{"issue":"3","key":"8088_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S1556-0864(15)31573-2","volume":"1","author":"AS Tsao","year":"2006","unstructured":"Tsao AS, Tang XM, Sabloff B, Xiao L, Shigematsu H, Roth J, et al. Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer. J Thorac Oncol. 2006;1(3):231\u20139.","journal-title":"J Thorac Oncol"},{"issue":"58","key":"8088_CR17","doi-asserted-by":"publisher","first-page":"98384","DOI":"10.18632\/oncotarget.21842","volume":"8","author":"CH Tseng","year":"2017","unstructured":"Tseng CH, Chiang CJ, Tseng JS, Yang TY, Chen KC, Hsu KH, et al. EGFR mutation, smoking, and gender in advanced lung adenocarcinoma. Oncotarget. 2017;8(58):98384\u201393.","journal-title":"Oncotarget"},{"key":"8088_CR18","doi-asserted-by":"publisher","first-page":"100400","DOI":"10.1016\/j.ejro.2022.100400","volume":"9","author":"AFH Ortiz","year":"2022","unstructured":"Ortiz AFH, Camacho TC, V\u00e1squez AF, del Castillo Herazo V, Neira JGA, Yepes MM, et al. Clinical and CT patterns to predict EGFR mutation in patients with non-small cell lung cancer: a systematic literature review and meta-analysis. Eur J Radiol Open. 2022;9:100400.","journal-title":"Eur J Radiol Open"},{"issue":"1","key":"8088_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12032-008-9160-1","volume":"27","author":"CT Huang","year":"2010","unstructured":"Huang CT, Yen RF, Cheng MF, Hsu YC, Wei PF, Tsai YJ, et al. Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma. Med Oncol. 2010;27(1):9\u201315.","journal-title":"Med Oncol"},{"issue":"5","key":"8088_CR20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00259-017-3885-z","volume":"45","author":"Z Lv","year":"2018","unstructured":"Lv Z, Fan J, Xu J, Wu F, Huang Q, Guo M, et al. Value of 18F-FDG PET\/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients. Eur J Nucl Med Mol Imaging. 2018;45(5):735\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"8088_CR21","doi-asserted-by":"publisher","first-page":"e044313","DOI":"10.1136\/bmjopen-2020-044313","volume":"11","author":"B Du","year":"2021","unstructured":"Du B, Wang S, Cui Y, Wang Z, Yang X, Wang M. Can 18F-FDG PET\/CT predict EGFR status in patients with non-small cell lung cancer? A systematic review and meta-analysis. BMJ Open. 2021;11(6):e044313.","journal-title":"BMJ Open"},{"issue":"4","key":"8088_CR22","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/1759-7714.12981","volume":"10","author":"L Zhu","year":"2019","unstructured":"Zhu L, Yin G, Chen W, Jiang M, Zhang Y, Li X, et al. Correlation between EGFR mutation status and 18F-FDG PET-CT image features in lung adenocarcinoma. Thorac Cancer. 2019;10(4):659\u201364.","journal-title":"Thorac Cancer"},{"issue":"2","key":"8088_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11604-022-01347-1","volume":"41","author":"M Ni","year":"2023","unstructured":"Ni M, Wang S, Ding N, Xu J, Lu Y, Han X, et al. Predictive value of intratumor metabolic and heterogeneity parameters on [18F]FDG PET\/CT for EGFR mutations in patients with lung adenocarcinoma. Jpn J Radiol. 2023;41(2):209\u201318.","journal-title":"Jpn J Radiol"},{"issue":"8","key":"8088_CR24","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/MNM.0000000000001043","volume":"40","author":"M Jiang","year":"2019","unstructured":"Jiang M, Zhang Y, Xu J, et al. Assessing EGFR gene mutation status in non-small cell lung cancer with imaging features from PET\/CT. Nucl Med Commun. 2019;40(8):842\u20139.","journal-title":"Nucl Med Commun"},{"key":"8088_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.894323","volume":"12","author":"L Yang","year":"2022","unstructured":"Yang L, Xu P, Li M, Wang M, Peng M, Zhang Y, et al. PET\/CT radiomic features: a potential biomarker for EGFR mutation status and survival outcome prediction in NSCLC patients treated with TKIs. Front Oncol. 2022;12:894323.","journal-title":"Front Oncol"},{"issue":"5","key":"8088_CR26","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00259-019-04592-1","volume":"47","author":"J Zhang","year":"2020","unstructured":"Zhang J, Zhao X, Zhao Y, Zhang J, Zhang Z, Wang J, et al. Value of pre-therapy 18F-FDG PET\/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2020;47(5):1137\u201346.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"8088_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/0846537119899526","volume":"72","author":"JKR Nair","year":"2021","unstructured":"Nair JKR, Saeed UA, McDougall CC, Sabri A, Kovacina B, Raidu BVS, et al. Radiogenomic models using machine learning techniques to predict EGFR mutations in non-small cell lung cancer. Can Assoc Radiol J. 2021;72(1):109\u201319.","journal-title":"Can Assoc Radiol J"},{"issue":"9","key":"8088_CR28","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3348\/kjr.2022.0295","volume":"23","author":"S Li","year":"2022","unstructured":"Li S, Li Y, Zhao M, Wang P, Xin J. Combination of 18F-fluorodeoxyglucose PET\/CT radiomics and clinical features for predicting epidermal growth factor receptor mutations in lung adenocarcinoma. Korean J Radiol. 2022;23(9):921\u201330.","journal-title":"Korean J Radiol"},{"key":"8088_CR29","doi-asserted-by":"publisher","first-page":"709137","DOI":"10.3389\/fonc.2021.709137","volume":"11","author":"G Yin","year":"2021","unstructured":"Yin G, Zheng X, Liu C, Song Y, Sun X, Liu Z, et al. Prediction of EGFR mutation status based on 18F-FDG PET\/CT imaging using deep learning-based model in lung adenocarcinoma. Front Oncol. 2021;11:709137.","journal-title":"Front Oncol"},{"issue":"5","key":"8088_CR30","first-page":"337","volume":"13","author":"JL Tan","year":"2023","unstructured":"Tan JL, Geng DY, Li Y, et al. Prediction of EGFR mutation status in lung adenocarcinoma using 18F-FDG PET\/CT radiomic features. Am J Nucl Med Mol Imaging. 2023;13(5):337\u201349.","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"8088_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13550-023-00977-4","volume":"13","author":"J Gao","year":"2023","unstructured":"Gao J, Sun J, Li H, et al. The predictive value of [18F]FDG PET\/CT radiomics combined with clinical parameters for EGFR mutation status in lung adenocarcinoma. EJNMMI Res. 2023;13:31.","journal-title":"EJNMMI Res"},{"key":"8088_CR32","doi-asserted-by":"publisher","first-page":"1173355","DOI":"10.3389\/fonc.2023.1173355","volume":"13","author":"Y Zuo","year":"2023","unstructured":"Zuo Y, Li X, Zhang H, Liu Q, Li N, Lin Y, et al. Optimal 18F-FDG PET\/CT radiomics model development for predicting EGFR mutation status and prognosis in lung adenocarcinoma: a multicentric study. Front Oncol. 2023;13:1173355.","journal-title":"Front Oncol"},{"issue":"7","key":"8088_CR33","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1002\/mp.16947","volume":"51","author":"Y Zuo","year":"2024","unstructured":"Zuo Y, Liu Q, Li N, Li X, Zhang H, Lin Y, et al. Value of multi-center 18F-FDG PET\/CT radiomics in identifying EGFR mutation status and EGFR subtypes in lung adenocarcinoma. Med Phys. 2024;51(7):4872\u201387.","journal-title":"Med Phys"},{"key":"8088_CR34","doi-asserted-by":"crossref","unstructured":"Zuo Y, Liu Q, Li N, Li X, Zhang H, Lin Y et al. Explainable 18F-FDG PET\/CT radiomics model for predicting EGFR mutation status in lung adenocarcinoma: a two-center study. Eur J Nucl Med Mol Imaging. 2024. Epub ahead of print.","DOI":"10.3389\/fonc.2023.1173355"},{"key":"8088_CR35","doi-asserted-by":"publisher","first-page":"1281572","DOI":"10.3389\/fonc.2024.1281572","volume":"14","author":"N Ma","year":"2024","unstructured":"Ma N, Yang Y, Wang Y, Cui Y, Hu X, Wu J. Predictive value of 18F-FDG PET\/CT radiomics for EGFR gene mutations in non-small cell lung cancer: a systematic review and meta-analysis. Front Oncol. 2024;14:1281572.","journal-title":"Front Oncol"},{"key":"8088_CR36","first-page":"4765","volume-title":"Advances in Neural Information Processing Systems 30","author":"SM Lundberg","year":"2017","unstructured":"Lundberg SM, Lee SI. A unified approach to interpreting model predictions. Advances in Neural Information Processing Systems 30. Red Hook, NY: Curran Associates; 2017. pp. 4765\u201374."}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08088-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-08088-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08088-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:31:45Z","timestamp":1790929905000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-08088-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["8088"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-08088-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"3 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The article was modified to correct the affiliations.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Zhejiang Cancer Hospital (IRB-2025-1342). Patient consent was waived due to the retrospective design of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}